Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
OCT-Guided Antithrombotics in Basilar Artery Stroke
NCT04121611Unknown
- Sponsor
- Sunnybrook Health Sciences Centre
- Start
- Oct 2019
- Primary completion
- Oct 2021
- Modality
- Recombinant Proteins and Enzymes, Orthosteric Ligands
- Countries
- 1
01
Overview
Open-label trial of heparin and aspirin in basilar artery occlusion (BAO) (2 arms), sponsored by Sunnybrook Health Sciences Centre. Primary endpoint: Favorable outcome at 90 days. Status: unknown.
02
Drugs
heparinaspirin
03
Conditions
basilar artery occlusion (BAO)
Beyond the preview
Go deeper on NCT04121611.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04121611.